An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re...
PHASE1
Background:
\- New vaccines against avian influenza, also known as "bird f...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally
PHASE1
This study will evaluate the safety and effectiveness of a vaccine to preve...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike